Percutaneous transluminal coronary angioplasty (PTCA) without on-site surgical facilities

Australian and New Zealand Journal of Medicine

Volumn 28, Issue 2, 1998, Pages 165-172

  Cheong, Y M ^a   Dick, R ^a   Sia, B ^a   Lim, Y L ^b   Cheong, Yew Mun ^a  

^a AUSTIN HEALTH   (Australia)

^b Box Hill Hospital   (Canada)

Author keywords

Australia; Percutaneous transluminal coronary angioplasty; Surgical standby

Indexed keywords

ABCIXIMAB;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; AUSTRALIA; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST CONTROL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; STENT; SURGICAL TECHNIQUE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 14444280166     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1998.tb02965.x     Document Type: Article

References (53)

1. Gruentzig A. Transluminal dilatation of coronary artery stenosis. Lancet 1978; 1: 263 (Letter).
2. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet 1993; 341: 573-80.
3. Pocock SJ, Henderson RA, Rickards AF et al. Metaanalysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995; 346: 1184-9.
4. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996; 335: 217-25.
5. Parisi AF, Holland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992; 326: 10-16.
6. Strauss WE, Fortin T, Hartigan P et al. and the ACME trial investigators. A comparison of quality of life scores in patients with angina pectoris after angioplasty compared with after medical therapy. Circulation 1995; 92: 1710-19.
7. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave myocardial infarction: results of the TIMI IIIB Trial. Circulation 1994; 89: 1545-56.
8. O'Keefe JH, Bailey WL, Rutherford BD, Hartzler GO. Primary angioplasty for acute myocardial infarction in 1000 consecutive patients. Am J Cardiol 1993; 72: 107G-115G.
9. Simari RD, Berger PB, Bell MR et al. Coronary angioplasty in acute myocardial infarction: Primary, Immediate adjunctive. Rescue or Deferred adjunctive approach? Mayo Clin Proc 1994; 69: 346-58.
10. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomised clinical trials. Circulation 1995; 91: 476-85.
11. Detre KM, Holmes DR, Holubkor R et al. and the investigators of the National Heart Lung and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. Incidence and consequences of periprocedural occlusion. The 1985-86 NHLBI PTCA Registry. Circulation 1990; 82: 739-50.
12. Ellis SG, Roubin GS, King SB et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988; 77: 372-9.
13. Lincoff AM, Popma JJ, Ellis SG et al. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992; 19: 926-35.
14. Ryan T and ACC/AHA Task force. Guidelines for Percutaneous Coronary Angioplasty. J Am Coll Cardiol 1993; 22: 2033-54.
15. Bredee JJ, Banvinck JH, Berreklouw E et al. Acute myocardial ischaemia and cardiogenic shock after percutaneous transluminal coronary angioplasty: risk factors for and results of emergency coronary bypass. Eur Heart J 1989; 10 (suppl H): 104-11.
16. de Feyter PJ, Vanden Brand M, Jaarman G et al. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Circulation 1991; 83: 927-36.
17. Naunheim KS, Fiore AC, Pagan DC et al. Emergency coronary artery bypass grafting for failed angioplasty: Risk factors and outcome. Ann Thorac Surg 1989; 47: 816-23.
18. Tuzcu M, Simpfendarfer C, Dorosti K et al. Long term outcome of unsuccessful percutaneous transluminal coronary angioplasty. Am Heart J 1990; 119: 791-6.
19. Fergusin TB, Muhlbaier LH, Salai DL et al. Coronary artery bypass grafting after failed elective and failed emergent percutaneous angioplasty: Relative risks of emergent surgical intervention. J Thorac Cardiovasc Surg 1988; 95: 761-72.
20. Kimmel SE, Berlin JA, Strom BL, Laskey WK. Development and validation of asimplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. J Am Coll Cardiol 1995; 26: 931-8.
21. Ellis SG, Vandormael MG, Cowley MJ et al. and the Multivessel Angioplasty Prognosis Study Group. Coronary morphologic and clinical disease: implications for patient selection. Circulation 1990; 82: 1193-202.
22. Sinclair IN, McCabe CH, Sipperly ME, Baim DS. Predictors, therapeutic options and long-term outcome of abrupt reclosure. Am J Cardiol 1988; 61: 61G-66G.
23. Roubin GS, Cannon AD, Agrawal SK et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992; 85: 916-27.
24. Herrmann HC, Buchbinder M, Clemen MW et al. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation 1992; 86: 812-19.
25. George BS, Voorhees WD III, Roubin GS et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical angiographie outcomes. J Am Coll Cardiol 1993; 22: 135-43.
26. Lincoff AM, Topol EJ, Chapekis AT et al. Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty: A matched case-control study. J Am Coll Cardiol 1993; 21: 866-75.
27. Schomig A, Kastrati A, Mudra H et al. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation 1994; 90: 2716-24.
28. Liu MW, Voorhees WD III, Agrawal S et al. Stratification of the risk of thrombosis after intracoronary stenting for threatened or acute closure complicating coronary balloon angioplasty: A Cook registry study. Am Heart J 1995; 130: 8-13.
29. Sutton JM, Ellis SG, Roubin GS et al. Major clinical events after coronary stenting. The Multicentre Registry of acute and elective Gianturco-Roubin stent placement. Circulation 1994; 89: 1126-37.
30. Schomig A, Kastrati A, Dietz R et al. Emergency coronary stenting for dissection during percutaneous transluminal coronary angioplasty: Angiographie follow-up after stenting and after repeat angioplasty of the stented segment. J Am Coll Cardiol 1994; 23: 1053-60.
31. Colombo A, Goldberg SL, Almagar Y et al. A novel strategy for stent deployment in the treatment of acute or threatened closure complicating balloon coronary angioplasty. Use of short or standard (or both) single or multiple Palmaz-Schatz stems. J Am Coll Cardiol 1993; 22: 1887-91.
32. Colombo A, Hall P, Nakamura S et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-88.
33. Hall P, Nakamura S, Maiello L et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996; 93:215-22.
34. Barragan P, Silvestri M, Sainsous J et al. Prevention of subacute occlusion after coronary stenting with ticlopidine regimen without intravascular ultrasound guided stenting. J Am Coll Cardiol 1995; 24: 182A.
35. van Belle E, McFadden EP, Lablanche JM et al. Two-pronged antiplatelet therapy with aspirin and ticlopidine without systemic anticoagulation: an alternative therapeutic strategy after bailout stent implantation. Coron Artery Dis 1995; 6: 341-5.
36. Morice MC, Zemour G, Beneviste E et al. Intracoronary stenting without coumadin: one month results of a French multicentre study. Cathet Cardiovasc Diagn 1995; 35: 1-7.
37. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med 1994; 330: 956-61.
38. Ricci DR, Buller CE, O'Neill B et al. Coronary stem versus prolonged perfusion balloon for failed coronary angioplasry - a randomized trial. Circulation 1994; 90:1-651 (Abstr.).
39. Kuntz RE, Piana R, Pomerantz RM et al. Changing incidence and management of abrupt closure following coronary intervention in the new device era. Cathet Cardiovasc Diagn 1992; 27: 183-90.
40. Rodriguez AE, Fernandez M, Santaera O et al. Coronary stenting in patients undergoing percutaneous transluminal coronary angioplasty during acute myocardial infarction. Am J Cardiol 1996; 77: 685-9.
41. Le May MR, Labinaz M, Beanlands RSB et al. Usefulness of intracoronary stenting in acute myocardial infarction. Am J Cardiol 1996; 78: 148-52.
42. Steffenino G, Dellavalle A, Ribichini F, Uslenghi E. Coronary stenting after unsuccessful emergency angioplasty in acute myocardial infarction: results in a series of consecutive patients. Am Heart J 1996; 132: 1115-8.
43. Ahmad T, Webb JG, Garere RR, Dodek A. Coronary stenting for acute myocardial infarction. Am J Cardiol 1995; 76: 77-80.
44. Richardson SG, Morton P, Murtagh JG et al. Management of acute coronary occlusion during percutaneous transluminal coronary angioplasty: experience of complications in a hospital without on site facilities for cardiac surgery. BMJ 1990; 300: 355-8.
45. Iniguez A, Macaya C, Hernandez R et al. Comparison of results of percutaneous transluminal coronary angioplasty with and without selective requirement of surgical standby. Am J Cardiol 1992; 69: 1161-5.
46. Meier B, Urban P, Dorsaz PA, Favre J. Surgical standby for coronary balloon angioplasty. JAMA 1992; 268: 741-5.
47. Reifart N, Schwarz F, Preusler W et al. Results of PTCA in more than 5000 patients without surgical standby in the same centre. J Am Coll Cardiol 1992; 19: 229A.
48. Shaw TRD, Starkey IR, Essop AR et al. Emergency coronary bypass surgery after vessel occlusion at angioplasty in centres without on-site facilities for cardiac surgery. Br Heart J 1989; 61: 438.
49. Dellavalle A, Steffenino G, Ribichini F et al. Elective coronary angioplasty with and without surgical standby: clinical and angiographie criteria for the selection of patients. Coron Artery Dis 1995; 6: 513-20.
50. Klinke WP, Hui W. Percutaneous transluminal coronary angioplasty without on-site surgical facilities. Am J Cardiol 1992; 70: 1520-5.
51. Berger PB, Stensrud PE, Daly RC et al. Time to reperfusion and other procedural characteristics of emergency coronary artery bypass surgery after unsuccessful coronary angioplasty. Am J Cardiol 1995; 76: 565-9.
52. Stauffer JC, Eeckhout E, Vogt P et al. Stand-by versus stent-by during percutaneous transluminal coronary angioplasty. Am Heart J 1995; 130: 21-6.
53. Altmann DB, Raez M, Battleman DS et al. Reduction in angioplasty complications after the introduction of coronary stents: Results from a consecutive series of 2242 patients. Am Heart J 1996; 132: 503-7.